• CureVac looks to subgroup to save failed COVID-19 vaccine as final analysis confirms sub-50% efficacy

    3 monthes ago - By Fierce Biotech

    CureVac looks to subgroup to save failed COVID-19 vaccine as final analysis confirms sub-50% efficacy ntaylor
    Thu, 07/01/2021 - 04:59
    Read more ...